Company Filing History:
Years Active: 2025
Title: **Junjie Liu: Innovator in CRISPR Technology**
Introduction
Junjie Liu is a prominent inventor based in Berkeley, California, recognized for his significant contributions to the field of genetic engineering. He holds a patent that focuses on variant type V CRISPR/Cas effector polypeptides, a cutting-edge innovation in biotechnology.
Latest Patents
Junjie Liu's notable patent, "Variant type V CRISPR/Cas effector polypeptides and methods of use thereof," provides innovative solutions involving variant type V CRISPR/Cas effector polypeptides and their applications. The disclosure outlines the creation of fusion polypeptides and nucleic acids that include nucleotide sequences encoding the variant polypeptides and their methods of use. This technology has advanced methods for binding, nicking target nucleic acids, and detecting single-stranded DNA, which are crucial for genetic research and therapeutic applications.
Career Highlights
Junjie Liu currently serves at the University of California, where he is involved in groundbreaking research in synthetic biology and genetic editing. His work exemplifies a commitment to advancing scientific understanding and practical applications of CRISPR technology.
Collaborations
Throughout his career, Junjie Liu has had the privilege of collaborating with renowned scientists, including Jennifer A. Doudna and Benjamin L. Oakes. These partnerships have further enhanced the development and application of innovative technologies in the field of genetic engineering.
Conclusion
Junjie Liu's contributions to the field of CRISPR technology showcase his position as an important innovator. With his patented work, he continues to influence advancements in genetic research, paving the way for new methods and applications in biotechnology. His collaborations with leading experts further bolster the impact of his inventions within the scientific community.